From: Cost-effectiveness of diagnostic tests for threatened preterm labor in singleton pregnancy in France
 | ∆E < 0 and ∆C < 0a | ∆E < 0 and ∆C > 0b | ∆E > 0 and ∆C < 0c | ∆E > 0 and ∆C > 0d |
---|---|---|---|---|
Strategies [24–27] GA | ||||
 S6: CL < 15 mm | 90 | 1 | 0 | 9 |
 Sref: CL < 25 mm | 24 | 47 | 0 | 29 |
 S2: Qualitative fFN | 20 | 47 | 0 | 33 |
 S3: Quantitative fFN | 26 | 23 | 0 | 51 |
 S4: Cervical IL-6 | 41 | 18 | 0 | 41 |
 S5: CL < 18 mm, plasma RANTES and plasma IL-10 | 27 | 24 | 0 | 49 |
Strategies [28–31] GA | ||||
 S6: CL < 15 mm | 92 | 0 | 3 | 5 |
 Sref: CL < 25 mm | 28 | 45 | 0 | 27 |
 S2: Qualitative fFN | 24 | 45 | 0 | 31 |
 S3: Quantitative fFN | 28 | 20 | 0 | 52 |
 S4: Cervical IL-6 | 44 | 17 | 0 | 39 |
 S5: CL < 18 mm, plasma RANTES and plasma IL-10 | 28 | 23 | 0 | 49 |
Strategies [32–34] GA | ||||
 S6: CL < 15 mm | 96 | 0 | 3 | 1 |
 Sref: CL < 25 mm | 59 | 25 | 3 | 13 |
 S2: Qualitative fFN | 54 | 26 | 3 | 17 |
 S3: Quantitative fFN | 43 | 12 | 5 | 41 |
 S4: Cervical IL-6 | 55 | 10 | 3 | 31 |
 S5: CL < 18 mm, plasma RANTES and plasma IL-10 | 45 | 14 | 5 | 36 |